These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20550533)

  • 101. Alteration in glucocorticoids secretion and metabolism in patients affected by cystic fibrosis.
    Podgórski R; Sumińska M; Rachel M; Fichna M; Fichna P; Mazur A
    Front Endocrinol (Lausanne); 2022; 13():1074209. PubMed ID: 36568105
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial.
    Larsen T; Mose FH; Bech JN; Pedersen EB
    BMC Nephrol; 2013 Jul; 14():163. PubMed ID: 23889806
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial.
    Hill NR; Lasserson D; Thompson B; Perera-Salazar R; Wolstenholme J; Bower P; Blakeman T; Fitzmaurice D; Little P; Feder G; Qureshi N; Taal M; Townend J; Ferro C; McManus R; Hobbs FR
    Trials; 2014 May; 15():160. PubMed ID: 24886488
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects.
    Garg R; Kneen L; Williams GH; Adler GK
    Diabetes Obes Metab; 2014 Mar; 16(3):268-72. PubMed ID: 24125483
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Cortisol excess in chronic kidney disease - A review of changes and impact on mortality.
    Sagmeister MS; Harper L; Hardy RS
    Front Endocrinol (Lausanne); 2022; 13():1075809. PubMed ID: 36733794
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Urinary corticosteroid excretion predicts left ventricular mass and proteinuria in chronic kidney disease.
    McQuarrie EP; Freel EM; Mark PB; Fraser R; Patel RK; Dargie HG; Connell JM; Jardine AG
    Clin Sci (Lond); 2012 Sep; 123(5):285-94. PubMed ID: 22397469
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial.
    Ng KP; Jain P; Gill PS; Heer G; Townend JN; Freemantle N; Greenfield S; McManus RJ; Ferro CJ
    BMJ Open; 2016 Feb; 6(2):e010519. PubMed ID: 26916697
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Effects of sodium intake, age, gender, blood sampling time on distribution of plasma aldosterone, renin activity, deoxycorticosterone, cortisol, cortisone, and 24 h urinary aldosterone levels in normotensive individuals based on LC-MS/MS.
    Zhang Q; Zhao Z; Cheng W; Zhang Y; Li Z; Liu H; Xu C; Wang K
    Endocrine; 2024 Jun; ():. PubMed ID: 38833202
    [TBL] [Abstract][Full Text] [Related]  

  • 109. A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial.
    Hayer MK; Edwards NC; Slinn G; Moody WE; Steeds RP; Ferro CJ; Price AM; Andujar C; Dutton M; Webster R; Webb DJ; Semple S; MacIntyre I; Melville V; Wilkinson IB; Hiemstra TF; Wheeler DC; Herrey A; Grant M; Mehta S; Ives N; Townend JN
    Am Heart J; 2017 Sep; 191():37-46. PubMed ID: 28888268
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Predisposing factors for adrenal crisis in chronic adrenal insufficiency: a case-control study.
    Chifu I; Burger-Stritt S; Schrader A; Herterich S; Freytag J; Kurlbaum M; Vogg N; Werner J; Quinkler M; Hahner S
    Eur J Endocrinol; 2023 Nov; 189(5):537-545. PubMed ID: 38006230
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Cortisol urinary metabolites in dogs with hypercortisolism, congestive heart failure, and healthy dogs: pilot investigation.
    Quilez E; Burchell RK; Thorstensen EB; Weidgraaf K; Parbhu SE; Lopez-Villalobos N; Gal A
    J Vet Diagn Invest; 2020 Mar; 32(2):317-323. PubMed ID: 31924129
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Efficacy and safety of a low-sodium diet and spironolactone in patients with stage 1-3a chronic kidney disease: a pilot study.
    Zhang H; Zhu B; Chang L; Ye X; Tian R; He L; Yu D; Chen H; Wang Y
    BMC Nephrol; 2022 Mar; 23(1):95. PubMed ID: 35247964
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Aldosterone-induced fibrosis in the kidney: questions and controversies.
    Brem AS; Morris DJ; Gong R
    Am J Kidney Dis; 2011 Sep; 58(3):471-9. PubMed ID: 21705125
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Responses of the renin-angiotensin-aldosterone system in pregnant chronic kidney disease patients with and without superimposed pre-eclampsia.
    Kurlak LO; Broughton Pipkin F; Mohaupt MG; Mistry HD
    Clin Kidney J; 2019 Dec; 12(6):847-854. PubMed ID: 31807298
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Decaying kidney function during cirrhosis correlates with remodeling of distal colon aldosterone target gene expression.
    Serrano-Morillas N; González-Alayón C; Vastola-Mascolo A; Rodríguez-Rodríguez AE; Hernández G; Porrini E; Hernández-Guerra M; Alvarez de la Rosa D
    Am J Physiol Gastrointest Liver Physiol; 2023 Oct; 325(4):G306-G317. PubMed ID: 37461846
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients.
    Gomez-Sanchez CE; Holland OB
    J Clin Endocrinol Metab; 1981 Feb; 52(2):214-9. PubMed ID: 7462387
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Role of Renin-Angiotensin-Aldosterone System and Cortisol in Endometriosis: A Preliminary Report.
    Sabbadin C; Saccardi C; Andrisani A; Vitagliano A; Marin L; Ragazzi E; Bordin L; Ambrosini G; Armanini D
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613755
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome.
    Torchen LC; Idkowiak J; Fogel NR; O'Neil DM; Shackleton CH; Arlt W; Dunaif A
    J Clin Endocrinol Metab; 2016 May; 101(5):2069-75. PubMed ID: 26990942
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.
    Bentley-Lewis R; Adler GK; Perlstein T; Seely EW; Hopkins PN; Williams GH; Garg R
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4472-5. PubMed ID: 17726083
    [TBL] [Abstract][Full Text] [Related]  

  • 120. NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo-DHF trial.
    Dumeny L; Vardeny O; Edelmann F; Pieske B; Duarte JD; Cavallari LH
    Pharmacotherapy; 2021 Dec; 41(12):978-987. PubMed ID: 34569641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.